Insider Transactions in Q4 2020 at Nabriva Therapeutics PLC (NBRV)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2020
|
Robert Crotty Gen Counsel & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
37
-0.18%
|
$74
$2.42 P/Share
|
|
Dec 31
2020
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
63
-0.18%
|
$126
$2.42 P/Share
|
|
Dec 31
2020
|
Jennifer Schranz Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
30
-0.18%
|
$60
$2.42 P/Share
|
|
Dec 31
2020
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
121
-0.19%
|
$242
$2.42 P/Share
|
|
Dec 31
2020
|
Gary Sender Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
32
-0.16%
|
$64
$2.42 P/Share
|
|
Nov 30
2020
|
Robert Crotty Gen Counsel & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
368
-0.18%
|
$0
$0.43 P/Share
|
|
Nov 30
2020
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
628
-0.18%
|
$0
$0.43 P/Share
|
|
Nov 30
2020
|
Jennifer Schranz Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
301
-0.18%
|
$0
$0.43 P/Share
|
|
Nov 30
2020
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,211
-0.19%
|
$0
$0.43 P/Share
|
|
Nov 30
2020
|
Gary Sender Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
312
-0.15%
|
$0
$0.43 P/Share
|
|
Oct 31
2020
|
Robert Crotty Gen Counsel & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
366
-0.18%
|
$0
$0.5 P/Share
|
|
Oct 31
2020
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
628
-0.17%
|
$0
$0.5 P/Share
|
|
Oct 31
2020
|
Jennifer Schranz Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
301
-0.18%
|
$0
$0.5 P/Share
|
|
Oct 31
2020
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,211
-0.19%
|
$0
$0.5 P/Share
|
|
Oct 31
2020
|
Gary Sender Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
312
-0.15%
|
$0
$0.5 P/Share
|